Gains May Be On The Menu For Hims & Hers Health Inc (NYSE: HIMS)

Currently, there are 209.44M common shares owned by the public and among those 177.28M shares have been available to trade.

The company’s stock has a 5-day price change of 6.24% and 145.03% over the past three months. HIMS shares are trading 284.61% year to date (YTD), with the 12-month market performance up to 284.61% higher. It has a 12-month low price of $8.09 and touched a high of $35.02 over the same period. HIMS has an average intraday trading volume of 15.47 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 24.71%, 47.00%, and 85.83% respectively.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Institutional ownership of Hims & Hers Health Inc (NYSE: HIMS) shares accounts for 56.05% of the company’s 209.44M shares outstanding.

It has a market capitalization of $8.10B and a beta (3y monthly) value of 1.25. The stock’s trailing 12-month PE ratio is 79.18, while the earnings-per-share (ttm) stands at $0.43. Price movements for the stock have been influenced by the stock’s volatility, which stands at 10.14% over the week and 12.47% over the month.

Earnings per share for the fiscal year are expected to increase by 824.74%, and 11.35% over the next financial year.

Needham coverage for the Hims & Hers Health Inc (HIMS) stock in a research note released on August 22, 2024 offered a Buy rating with a price target of $24. Imperial Capital was of a view on August 09, 2024 that the stock is In-line, while Citigroup gave the stock Neutral rating on May 22, 2024, issuing a price target of $16- $20. Jefferies on their part issued Hold rating on April 16, 2024.

Most Popular

Related Posts